了解多发性硬化症病理生理学和当前疾病修饰疗法:对未解决的方面进行审查
1Kuwait Cancer Control Centre, Department of Medical Laboratory, Molecular Genetics Laboratory, Ministry of Health, 13001 Shuwaikh, Kuwait.
Frontiers in bioscience (Landmark edition)
|November 30, 2024
概括
多发性硬化症 (MS) 治疗可以改善生活质量,但不能阻止疾病的进展. 需要进一步的研究来解决了解多发性硬化症病理生理学的差距,并开发更有效的治疗方法.
科学领域:
- 神经免疫学 神经免疫学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 多发性硬化症 (MS) 是一种中枢神经系统 (CNS) 自免疫性疾病,具有复杂的,尚未完全理解的病因学和病理生理学.
- 目前的疾病修饰疗法 (DMT) 可以改善生活质量,但不能完全预防MS的进展或复发.
研究的目的:
- 审查当前对MS病理生理学的理解.
- 确定现有的DMT中对MS的差距.
- 解释当前治疗方法在阻止多发性硬化症进展方面的局限性.
主要方法:
- 对MS病理生理学和DMT现有研究的文献综述.
主要成果:
- 尽管取得了进展,但目前的DMT仍然没有解决MS病理生理学的重要方面.
- 许多多发性硬化患者继续经历疾病进展或复发,表明治疗局限性.
结论:
- 更深入地了解MS病理生理学至关重要.
- 需要有针对性的疗法来弥补当前DMT的差距,以改善患者的长期治疗结果.
相关概念视频
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
460
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
460
Inflammatory Bowel Disease IV: Pharmacological Management
113
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
113
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Autoimmune Disorders
389
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
389
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39


